These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1571653)

  • 61. The effect of pravastatin on coronary events after myocardial infarction.
    Hazzard WR; Ettinger WH
    N Engl J Med; 1997 Mar; 336(13):961; author reply 962. PubMed ID: 9072700
    [No Abstract]   [Full Text] [Related]  

  • 62. Cholesterol lowering and mortality: a great success story!
    Trevisan M; Stranges S
    Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):391-4. PubMed ID: 16875804
    [No Abstract]   [Full Text] [Related]  

  • 63. [Anion exchange resin].
    Nakaya N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():642-9. PubMed ID: 11347147
    [No Abstract]   [Full Text] [Related]  

  • 64. [Use of statins in primary prevention: from the theoretical presuppositions to complex scenarios of the real world].
    Poli A; Menotti A
    G Ital Cardiol; 1999 Oct; 29(10):1123-30. PubMed ID: 10546121
    [No Abstract]   [Full Text] [Related]  

  • 65. Coronary risk assessment methods and cholesterol lowering.
    Smith GD; Ebrahim S
    Lancet; 1999 Mar; 353(9158):1097. PubMed ID: 10199372
    [No Abstract]   [Full Text] [Related]  

  • 66. Mulling over the odds of CETP inhibition.
    von Eckardstein A
    Eur Heart J; 2010 Feb; 31(4):390-3. PubMed ID: 20097704
    [No Abstract]   [Full Text] [Related]  

  • 67. [Cholesterol-lowering therapy; a recommendation from the Health Council].
    Comans ML
    Ned Tijdschr Geneeskd; 2001 Feb; 145(5):244. PubMed ID: 11219155
    [No Abstract]   [Full Text] [Related]  

  • 68. Lessons from torcetrapib: putting patient-oriented evidence first.
    Ewart RM
    Am Fam Physician; 2008 Mar; 77(5):597-8. PubMed ID: 18350757
    [No Abstract]   [Full Text] [Related]  

  • 69. Screening for high blood cholesterol. U.S. Preventive Services Task Force.
    Am Fam Physician; 1990 Feb; 41(2):503-13. PubMed ID: 2405605
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Communicating the risk reduction achieved by cholesterol reducing drugs.
    Skolbekken JA
    BMJ; 1998 Jun; 316(7149):1956-8. PubMed ID: 9641937
    [No Abstract]   [Full Text] [Related]  

  • 71. Changing the treatment paradigm for coronary artery disease.
    Esselstyn CB
    Am J Cardiol; 1998 Nov; 82(10B):2T-4T. PubMed ID: 9860365
    [No Abstract]   [Full Text] [Related]  

  • 72. Plant sterols...from research to practice.
    Betteridge DJ
    Atheroscler Suppl; 2002 Oct; 3(3):1-3. PubMed ID: 12429166
    [No Abstract]   [Full Text] [Related]  

  • 73. The cholesterol controversy.
    Tobert JA
    BMJ; 1992 Mar; 304(6828):713. PubMed ID: 1571657
    [No Abstract]   [Full Text] [Related]  

  • 74. The search beyond statins.
    Wenner Moyer M
    Nat Med; 2010 Feb; 16(2):150-3. PubMed ID: 20134459
    [No Abstract]   [Full Text] [Related]  

  • 75. The cholesterol controversy.
    Thomas P
    BMJ; 1992 Apr; 304(6831):912. PubMed ID: 1392765
    [No Abstract]   [Full Text] [Related]  

  • 76. Should clofibrate still be prescribed?
    Dunnigan MG
    BMJ; 1992 Aug; 305(6850):379-80. PubMed ID: 1392914
    [No Abstract]   [Full Text] [Related]  

  • 77. The cholesterol controversy.
    Reckless JP
    BMJ; 1992 Mar; 304(6828):712. PubMed ID: 1571653
    [No Abstract]   [Full Text] [Related]  

  • 78. The cholesterol controversy.
    Winder T
    BMJ; 1992 Mar; 304(6828):712-3. PubMed ID: 1571655
    [No Abstract]   [Full Text] [Related]  

  • 79. Cholesterol in perspective.
    Forge BH
    Med J Aust; 1999 Apr; 170(8):385-90. PubMed ID: 10327953
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Absolute benefit from cholesterol lowering in diabetic patients with coronary heart disease.
    Strandberg TE
    Diabetes Care; 1997 Sep; 20(9):1495-6. PubMed ID: 9283807
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.